Zerion News

Press Releases
|
November 24, 2021

Zerion Pharma ApS extends its licensing agreement with Rousselot B.V to exploit Dispersome® technology platform

24 November, 2021 (COPENHAGEN, Denmark). Rousselot B.V. and Zerion Pharma ApS announce today that they have strengthened their partnership through an extension of

Press Releases
|
May 10, 2021

ZERION PHARMA elects Dr. Torsten Goesch and Dr. Lars Lykke Thomsen as new board members

(Copenhagen, May 10, 2021). ZERION Pharma, a Danish pharmaceutical company, elected two new members Dr. Torsten Goesch and Dr. Lars Lykke Thomsen to join its board of directors at the annual general meeting held...

Zerion Team
|
April 8, 2021

Zerion Team in Numbers

An international and very diverse team is behind Zerion Pharma – a drug development company improving the formulation of poorly soluble drugs that are currently not reaching their therapeutical potential...

Zerion Team
|
March 12, 2021

ZERION Pharma expands its team with a Communications Specialist and a Formulation Technician

Ieva Jasiukenaite is joining ZERION’s commercial team as a Communications Specialist and Camila Belavi is joining ZERION’s R&D team as a Laboratory Technician. Both already joined ZERION during February and March...

Press Releases
|
February 9, 2021

Arla Foods Ingredients and ZERION announce agreement to secure supply of Lacprodan® BLG as key component in ZERION’s Dispersome® technology

(Copenhagen, February 9, 2021). Arla Foods Ingredients Group P/S (Arla), a subsidiary of Arla Foods amba, and drug formulation company Zerion ApS (ZERION) have entered into an agreement covering the supply of...

Zerion Team
|
January 4, 2021

ZERION expands its R&D team with Analytical Scientist and Scientific Director of Formulation to strengthen the company’s pipeline activities

Dr. Anis Arnous and Dr. Søren Vinter Søgaard will join ZERION’s R&D team as Analytical Scientist and Scientific Director...

Zerion Pharma in Press